187 related articles for article (PubMed ID: 2158397)
21. Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological, and growth properties.
Gazdar AF; Carney DN; Nau MM; Minna JD
Cancer Res; 1985 Jun; 45(6):2924-30. PubMed ID: 2985258
[TBL] [Abstract][Full Text] [Related]
22. Characterization of five new cell lines derived from human primitive neuroectodermal tumors of the central nervous system.
Pietsch T; Scharmann T; Fonatsch C; Schmidt D; Ockler R; Freihoff D; Albrecht S; Wiestler OD; Zeltzer P; Riehm H
Cancer Res; 1994 Jun; 54(12):3278-87. PubMed ID: 8205550
[TBL] [Abstract][Full Text] [Related]
23. The c-myc protein is constitutively expressed at elevated levels in colorectal carcinoma cell lines.
Erisman MD; Scott JK; Watt RA; Astrin SM
Oncogene; 1988 Apr; 2(4):367-78. PubMed ID: 3283655
[TBL] [Abstract][Full Text] [Related]
24. Changes in the phenotype of human small cell lung cancer cell lines after transfection and expression of the c-myc proto-oncogene.
Johnson BE; Battey J; Linnoila I; Becker KL; Makuch RW; Snider RH; Carney DN; Minna JD
J Clin Invest; 1986 Aug; 78(2):525-32. PubMed ID: 3016030
[TBL] [Abstract][Full Text] [Related]
25. Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification.
Cohn SL; Salwen H; Quasney MW; Ikegaki N; Cowan JM; Herst CV; Kennett RH; Rosen ST; DiGiuseppe JA; Brodeur GM
Oncogene; 1990 Dec; 5(12):1821-7. PubMed ID: 2284101
[TBL] [Abstract][Full Text] [Related]
26. Amplification and expression of protooncogenes in human small cell lung cancer cell lines.
Kiefer PE; Bepler G; Kubasch M; Havemann K
Cancer Res; 1987 Dec; 47(23):6236-42. PubMed ID: 2824028
[TBL] [Abstract][Full Text] [Related]
27. Increased level of amplification of the c-myc oncogene in tumors induced in nude mice by a human breast carcinoma cell line.
Modjtahedi N; Lavialle C; Poupon MF; Landin RM; Cassingena R; Monier R; Brison O
Cancer Res; 1985 Sep; 45(9):4372-9. PubMed ID: 4028021
[TBL] [Abstract][Full Text] [Related]
28. Effects of c-myc oncogene modulation on differentiation of human small cell lung carcinoma cell lines.
van Waardenburg RC; Meijer C; Pinto-Sietsma SJ; de Vries EG; Timens W; Mulder NM
Anticancer Res; 1998; 18(1A):91-5. PubMed ID: 9568061
[TBL] [Abstract][Full Text] [Related]
29. Amplification of the c-myc oncogene in one of five human breast carcinoma cell lines.
Kozbor D; Croce CM
Cancer Res; 1984 Feb; 44(2):438-41. PubMed ID: 6692352
[TBL] [Abstract][Full Text] [Related]
30. Expression of growth factors and oncogenes in normal and tumor-derived human mammary epithelial cells.
Zajchowski D; Band V; Pauzie N; Tager A; Stampfer M; Sager R
Cancer Res; 1988 Dec; 48(24 Pt 1):7041-7. PubMed ID: 3191480
[TBL] [Abstract][Full Text] [Related]
31. Antigenic phenotype and biological characteristics of two distinct sublines derived from a small cell lung carcinoma cell line.
Watanabe H; Takahashi T; Ueda R; Utsumi KR; Sato T; Ariyoshi Y; Ota K; Obata Y; Takahashi T
Cancer Res; 1988 May; 48(9):2544-9. PubMed ID: 2833350
[TBL] [Abstract][Full Text] [Related]
32. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization.
Jenkins RB; Qian J; Lieber MM; Bostwick DG
Cancer Res; 1997 Feb; 57(3):524-31. PubMed ID: 9012485
[TBL] [Abstract][Full Text] [Related]
33. Amplification, expression and localization of the c-myc gene in BSp73 rat tumor cell lines.
Birnbaum M; Spiess E
Anticancer Res; 1988; 8(6):1185-91. PubMed ID: 2464334
[TBL] [Abstract][Full Text] [Related]
34. Establishment and characterization of three new continuous cell lines derived from human breast carcinomas.
Engel LW; Young NA; Tralka TS; Lippman ME; O'Brien SJ; Joyce MJ
Cancer Res; 1978 Oct; 38(10):3352-64. PubMed ID: 688225
[TBL] [Abstract][Full Text] [Related]
35. Frequent amplification of the c-met gene in scirrhous type stomach cancer.
Kuniyasu H; Yasui W; Kitadai Y; Yokozaki H; Ito H; Tahara E
Biochem Biophys Res Commun; 1992 Nov; 189(1):227-32. PubMed ID: 1333188
[TBL] [Abstract][Full Text] [Related]
36. Novel DNA sequences at chromosome 10q26 are amplified in human gastric carcinoma cell lines: molecular cloning by competitive DNA reassociation.
Mor O; Messinger Y; Rotman G; Bar-Am I; Ravia Y; Eddy RL; Shows TB; Park JG; Gazdar AF; Shiloh Y
Nucleic Acids Res; 1991 Jan; 19(1):117-23. PubMed ID: 2011492
[TBL] [Abstract][Full Text] [Related]
37. DNA amplification in human gastric carcinomas.
Mor O; Ranzani GN; Ravia Y; Rotman G; Gutman M; Manor A; Amadori D; Houldsworth J; Hollstein M; Schwab M; Shiloh Y
Cancer Genet Cytogenet; 1993 Feb; 65(2):111-4. PubMed ID: 8453595
[TBL] [Abstract][Full Text] [Related]
38. Marker properties of tumor and lymphoid cell lines derived from a patient with squamous cell carcinoma.
Morgan RT; Quinn LA; Woods LK; Moore GE
Cancer Res; 1977 Jul; 37(7 Pt 1):2030-5. PubMed ID: 301054
[TBL] [Abstract][Full Text] [Related]
39. An inducible cell line (Natasha), from a neuroblastoma patient with circulating HSR-positive blasts, expressing neurohormones.
Melino G; Vernole P; Annicchiarico-Petruzzelli M; Stephanou A; Colantoni A; Knight RA; Spagnoli LG; Finazzi-Agro A
Anticancer Res; 1992; 12(4):1199-206. PubMed ID: 1503409
[TBL] [Abstract][Full Text] [Related]
40. Cell lines from human colon carcinoma with unusual cell products, double minutes, and homogeneously staining regions.
Quinn LA; Moore GE; Morgan RT; Woods LK
Cancer Res; 1979 Dec; 39(12):4914-24. PubMed ID: 498117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
